Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predictive Value of the PREMM5, MMRpredict Models, and the Universal Tumor Screening Strategy for Lynch Syndrome in Vietnam

NCT06863038 is registered in ClinicalTrials.gov with University of Medicine and Pharmacy at Ho Chi Minh City as lead sponsor.

NCT NCT06863038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06863038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predictive Value of the PREMM5, MMRpredict Models, and the Universal Tumor Screening Strategy for Lynch Syndrome in Vietnam
Lead sponsor
University of Medicine and Pharmacy at Ho Chi Minh City
Phase
Observational
Overall status
Not yet recruiting
Start date
March 17, 2025
Completion date
November 30, 2027
Enrollment
572 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer (crc), lynch syndrome